Mahmood Naderi
Overview
Explore the profile of Mahmood Naderi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pejman Sani M, Mohseni S, Samimi H, Nasiri S, Fallahi B, Mohajeri-Tehrani M, et al.
J Diabetes Metab Disord
. 2025 Feb;
24(1):68.
PMID: 39980844
Objectives: Thyroid cancer (TC) is commonly recognized as the most prevalent type of malignancy affecting the endocrine system. This study aimed to assess the incidence of TC and its trends...
2.
Gholizadeh Siahmazgi Z, Irani S, Ghiaseddin A, Soutodeh F, Gohari Z, Afifeh J, et al.
Res Pharm Sci
. 2025 Feb;
19(6):669-682.
PMID: 39911899
Background And Purpose: Xanthohumol (Xn), a small molecule found in , has shown promise as an anti-cancer compound. This in silico study was performed to understand the mechanism of action...
3.
Sotoudeh M, Mansouri V, Shakeri R, Sharififard B, Sajadi N, Haghpanah V, et al.
Expert Opin Ther Targets
. 2023 Dec;
27(12):1299-1305.
PMID: 38069509
Aims: Despite the promise of immunotherapy for gastric adenocarcinoma, resistance is common, necessitating the validation of new targets. Based on our previous bioinformatics analysis, the MUC3A antigen emerged as a...
4.
Samimi H, Tavakoli R, Fallah P, Naderi Sohi A, Amini Shirkouhi M, Naderi M, et al.
Cancer Cell Int
. 2022 Dec;
22(1):388.
PMID: 36482411
Background: Anaplastic thyroid carcinoma (ATC) is the most aggressive subtype of thyroid cancer. In this study, we used a three-dimensional in vitro system to evaluate the effect of a dual...
5.
Ghafouri F, Cohan R, Samimi H, Rad S M A, Naderi M, Noorbakhsh F, et al.
JMIR Bioinform Biotechnol
. 2022 Jul;
3(1):e36100.
PMID: 35891920
Background: Since the first appearance of SARS-CoV-2 in China in December 2019, the world witnessed the emergence of the SARS-CoV-2 outbreak. Due to the high transmissibility rate of the virus,...
6.
Naderi M, Nadri S
Int J Artif Organs
. 2022 Jun;
45(7):623-630.
PMID: 35658561
A variety of genes and materials can induce the differentiation of stem cells. The purpose of this work was to investigate the effect of microRNA-9 (miR-9) overexpression and electrical induction...
7.
Sotoudeh M, Mansouri V, Shakeri R, Sharififard B, Sajadi N, Naderi M
Immunotherapy
. 2022 Mar;
14(7):531-538.
PMID: 35321580
Mesothelin (MSLN) was applied for the immunotherapy of ovarian cancer and mesothelioma with a minimum expression of 60% to obtain a clinical response. Here, the authors evaluated MSLN expression as...
8.
Taghizadeh M, Kargarfard M, Braune S, Jung F, Naderi M
Clin Hemorheol Microcirc
. 2021 Aug;
80(2):107-116.
PMID: 34420942
Background: Type two diabetes mellitus (T2DM) patients are prone to develop atherothrombotic events due to platelet hyper-reactivity stemming from platelet miRNA-223 down-regulation and over-expression of its corresponding target, P2RY12. Objective:...
9.
Monzavi S, Naderi M, Ahmadbeigi N, Kajbafzadeh A, Muhammadnejad S
Cell Immunol
. 2021 Jul;
367:104398.
PMID: 34217004
Although not a standard-of-care yet, adoptive immunotherapeutic approaches have gradually earned a place within the list of antiviral therapies for some of fatal and hard-to-treat viral diseases. To maintain robust...
10.
Shiee M, Kia E, Zahabiun F, Naderi M, Motevaseli E, Nekoeian S, et al.
Parasit Vectors
. 2021 Apr;
14(1):197.
PMID: 33845889
Background: Cystic echinococcosis (CE) is a disease caused by the larval stage of Echinococcus granulosus sensu lato (s.l.). The treatment of CE mainly relies on the use of benzimidazoles, which...